RICHARDSON ELECTRONICS, LTD.
For the period ended Apr 9, 2025. Filed Apr 9, 2025.
View on SEC.govAbout this filing
A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.
Apr 9, 2025 · Filed Apr 9, 2025
Use the contents to explore the available documents and sections.
Contents
EX-99.1 · (continued)
(continued)
Non-GAAP Income Tax Benefit or Expense: Non-GAAP Income Tax Benefit or Expense is income tax (benefit) provision, adjusted to exclude a one-time loss on the sale of assets of the Company’s Healthcare business. The following table represents the Company’s calculation of non-GAAP Income Tax (Benefit) Expense for the periods presented and a reconciliation to the most directly comparable GAAP financial measure:
| Unaudited ($ in thousands) | ||||
|---|---|---|---|---|
| Three Months Ended | Nine Months Ended | |||
| March 1, 2025 | March 2, 2024 | March 1, 2025 | March 2, 2024 | |
| Income tax (benefit) provision | $(1,031) | $229 | $(1,277) | $116 |
| Disposal of Healthcare assets | 1,278 | — | 1,278 | — |
| Non-GAAP Income Tax Benefit or Expense | $247 | $229 | $1 | $116 |
Non-GAAP Net Income: Non-GAAP Net Income is net (loss) income, adjusted to exclude a one-time loss on the sale of assets of the Company’s Healthcare business. The following table represents the Company’s calculation of non-GAAP Net Income for the periods presented and a reconciliation to the most directly comparable GAAP financial measure:
| Unaudited ($ in thousands) | ||||
|---|---|---|---|---|
| Three Months Ended | Nine Months Ended | |||
| March 1, 2025 | March 2, 2024 | March 1, 2025 | March 2, 2024 | |
| Net (loss) income | $(2,057) | $750 | $(2,218) | $180 |
| Disposal of Healthcare assets | 3,638 | — | 3,638 | — |
| Non-GAAP Net Income | $1,581 | $750 | $1,420 | $180 |
Non-GAAP Earnings Per Common Share (Diluted): Non-GAAP Earnings Per Common Share (Diluted) is net (loss) income per share (diluted), adjusted to exclude a one-time loss on the sale of assets of the Company’s Healthcare business. The following table represents the Company’s calculation of non-GAAP Earnings Per Common Share (diluted) for the periods presented and a reconciliation to the most directly comparable GAAP financial measure:
| Unaudited ($ in thousands) | ||||
|---|---|---|---|---|
| Three Months Ended | Nine Months Ended | |||
| March 1, 2025 | March 2, 2024 | March 1, 2025 | March 2, 2024 | |
| Net (loss) income per share (diluted) | $(0.15) | $0.05 | $(0.16) | $0.01 |
| Loss on sale of Healthcare assets | 0.26 | — | 0.26 | — |
| Non-GAAP Earnings Per Common Share (Diluted) | $0.11 | $0.05 | $0.10 | $0.01 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.